Detection of viral DNA to evaluate outcome of antiviral treatment of patients with recurrent genital herpes

Journal of Clinical Microbiology

Volumn 34, Issue 3, 1996, Pages 657-663

  Diaz Mitoma, Francisco ^a,b   Ruben, Martha ^a   Sacks, Stephen ^c   MaCpherson, Paul ^a   Caissie, Gilberts ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FAMCICLOVIR; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; GENITAL HERPES; HERPES SIMPLEX VIRUS 1; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; SOUTHERN BLOTTING; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS EXCRETION;

EID: 0030040591     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.3.657-663.1996     Document Type: Article

References (10)

1. Arvin, A. M., P. A. Hensleigh, C. G. Prober, D. S. Au, L. L. Yasukawa, A. E. Wittek, P. E. Palumbo, S. G. Paryani, and A. S. Yeager. 1986. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N. Engl. J. Med. 315:796-800.
2. Bacon, T. H., and R. F. Schinazi. 1993. An overview of the further evaluation of penciclovir against herpes simplex virus and varicella-zoster virus in cell culture highlighting contrasts with acyclovir. Antiviral Chem Chemother 4(Suppl. 1):25-36.
3. Brown, Z. A., J. Benedetti, R. Ashley, et al. 1991. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N. Engl. J. Med. 324:1247-1252.
4. Coleman, R. M., L. Pereira, P. D. Bailey, D. Dondero, C. Wickliffe, and A. J. Nahmias. 1983. Determination of herpes simplex virus type-specific antibodies by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 18:287-291.
5. Cone, R. W., A. C. Hobson, Z. Brown, R. Ashley, S. Berry, C. Winter, and L. Corey. 1994. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA 272:792-796.
6. Sollender, W. M., L. L. Yasukawa, M. Schwarte, L. Pereira, P. A. Hensleigh, C. G. Prober, and A. M. Arvin. 1988. Type-specific antibodies to herpes simplex type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J. Infect. Dis. 157:164-171.
7. Vere Hodge, R. A., and Y.-C. Chang. 1993. The mode of action of penciclovir. Antiviral Chem. Chemother. 4(Suppl. 1):13-24.
8. Vere Hodge, R. A., and R. Perkins. 1989. Mode of action of 9-(4-hydroxymethylbut-1)-guanine (BRL 39123) against herpes simplex virus in MRC-5 cells Antimicrob. Agents Chemother. 33:223-229.
9. Whitley, R. J., L. Corey, A. Arvin, F. D. Lakeman, C. V. Sumaya, P. F. Wright, L. M. Dunkle, S. J. Soong, and A. J. Nahmias. 1988. Changing presentation of herpes simplex virus infection in neonates. J. Infect. Dis. 158:109-116.
10. Whitley, R. J., A. Yeager, P. Kartus, Y. Bryson, J. D. Connor, A. J. Nahmias, and S. J. Soong. 1983. Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics 72:778-785.